CompletedNCT00018603
Guanfacine for the Treatment of PTSD (PTSD)
Medication studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- West HavenSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateNovember 1999
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- US Department of Veterans Affairs
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00018603
- Official title
Show the full official title
Guanfacine for the Treatment of PTSD
Recruitment & locations
CompletedWest Haven
Questions about this study
Who is behind this study?
The study sponsor is US Department of Veterans Affairs.
Did this study involve medication?
Yes. The study involved medication, including guanfacine.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me